These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Consent to medical treatment in Canada. Picard EI Osgoode Hall Law J; 1981 Mar; 19(1):140-51. PubMed ID: 11658624 [No Abstract] [Full Text] [Related]
23. Informed consent, termination of medical treatment, and the Federal Tort Claims Act: a new proposal for the military health care system. Deardorff SE Mil Law Rev; 1987 Jan; 115():1-120. PubMed ID: 11658904 [No Abstract] [Full Text] [Related]
24. Live organ donors and informed consent. A difficult minuet. Adams RK J Leg Med; 1987 Dec; 8(4):555-86. PubMed ID: 3323386 [No Abstract] [Full Text] [Related]
25. Duty of drug manufacturers to warn. Feldman v. Lederle Laboratories. Fern FH; Sichel WM Health Matrix; 1985; 3(2):58-67. PubMed ID: 10272774 [No Abstract] [Full Text] [Related]
26. Reducing punitive damages punishes only victims. Milazzo VL Natl Med Leg J; 1995; 6(4):2-3. PubMed ID: 8695749 [No Abstract] [Full Text] [Related]
27. The Pharmacist's duty to warn. Beneficial impact on quality of care, economically sound, and commensurate with federal law. Clowdis WG J Leg Med; 2010 Jul; 31(3):287-302. PubMed ID: 20830639 [No Abstract] [Full Text] [Related]
28. Rationalizing risk assessment in human subject research. Coleman CH Ariz Law Rev; 2004; 46(1):1-51. PubMed ID: 16189913 [No Abstract] [Full Text] [Related]
29. Dilemma of Tarasoff: must physicians protect the public or their patients? Roth MD; Levin LJ Law Med Health Care; 1983 Jun; 11(3):104-10, 131. PubMed ID: 6560175 [No Abstract] [Full Text] [Related]
30. The package insert and the pharmacist's liability. Simonsmeier LM Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428 [No Abstract] [Full Text] [Related]
31. Surrogate consent and the incompetent experimental subject. Bein PM Food Drug Cosmet Law J; 1991 Sep; 46(5):739-71. PubMed ID: 11651381 [No Abstract] [Full Text] [Related]
32. Liability and compensation aspects of immunization injury: a call for reform. McIntosh WK Osgoode Hall Law J; 1980 Dec; 18(4):584-613. PubMed ID: 11658622 [No Abstract] [Full Text] [Related]
33. Confronting a new obstacle to reproductive choice: encouraging the development of RU-486 through reform of products liability law. Rubin LA Rev Law Soc Change; 1990-1991; 18(1):131-59. PubMed ID: 11656168 [No Abstract] [Full Text] [Related]
34. Nursing home restraints and legal liability. Merging the standard of care and industry practice. Kapp MB J Leg Med; 1992 Mar; 13(1):1-32. PubMed ID: 1619351 [No Abstract] [Full Text] [Related]
35. Autonomy and privacy: protecting patients from their physicians. Bobinski MA Univ Pittsbg Law Rev; 1994; 55(2):291-388. PubMed ID: 11659957 [No Abstract] [Full Text] [Related]
36. Tardive dyskinesia: medical facts and legal fictions. Taub S St Louis Univ Law J; 1986; 30(3):833-75. PubMed ID: 11649880 [No Abstract] [Full Text] [Related]
37. Involuntary psychiatric hospitalization: a review of the statutes regulating the social control of the mentally ill. Gove WR; Tovo M; Hughes M Deviant Behav; 1985; 6():287-318. PubMed ID: 11658830 [No Abstract] [Full Text] [Related]
38. Toward uniform application of a federal psychotherapist-patient privilege. Baytion CM Wash Law Rev; 1995 Jan; 70(1):153-75. PubMed ID: 11660174 [No Abstract] [Full Text] [Related]
39. Scientific uncertainty in regulating deliberate release of genetically engineered organisms: substantive judicial review and institutional alternatives. Deatherage SD HELR Harvard Environ Law Rev; 1987; 11(1):203-46. PubMed ID: 11650817 [No Abstract] [Full Text] [Related]
40. Beyond Animal Legal Defense Fund v. Quigg: the controversy over transgenic animal patents continues. Hecht EJ Am Univ Law Rev; 1992; 41(3):1023-74. PubMed ID: 11652629 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]